(Q46912176)

26 December 2017

title

NIDA522131, a new radioligand for imaging extrathalamic nicotinic acetylcholine receptors: in vitro and in vivo evaluation (English)

1 reference

26 December 2017

author name string

Svetlana I Chefer

1

1 reference

26 December 2017

Olga A Pavlova

2

1 reference

26 December 2017

Yi Zhang

3

1 reference

26 December 2017

D Bruce Vaupel

4

1 reference

26 December 2017

Alane S Kimes

5

1 reference

26 December 2017

Andrew G Horti

6

1 reference

26 December 2017

Elliot Stein

7

1 reference

26 December 2017

Alexey G Mukhin

8

1 reference

26 December 2017

language of work or name

English

0 references

publication date

6 November 2007

1 reference

26 December 2017

Journal of Neurochemistry

number of pages

10

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

26 December 2017

volume

104

1 reference

26 December 2017

issue

2

1 reference

26 December 2017

page(s)

306-315

1 reference

26 December 2017

Positron emission tomography microdosing: a new concept with application in tracer and early clinical drug development

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.05009.X

Cigarette smoking saturates brain alpha 4 beta 2 nicotinic acetylcholine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.05009.X

Graphical analysis of 2-[18F]FA binding to nicotinic acetylcholine receptors in rhesus monkey brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.05009.X

Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.05009.X

Whole-body biodistribution, radiation absorbed dose, and brain SPET imaging with [123i]5-i-A-85380 in healthy human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.05009.X

In vitro characterization of 6-[18F]fluoro-A-85380, a high-affinity ligand for alpha4beta2* nicotinic acetylcholine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.05009.X

2-[18F]Fluoro-A-85380, an in vivo tracer for the nicotinic acetylcholine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.05009.X

2-, 5-, and 6-Halo-3-(2(S)-azetidinylmethoxy)pyridines: synthesis, affinity for nicotinic acetylcholine receptors, and molecular modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.05009.X

5-Iodo-A-85380 binds to alpha-conotoxin MII-sensitive nicotinic acetylcholine receptors (nAChRs) as well as alpha4beta2* subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.05009.X

Simplified reference tissue model for PET receptor studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.05009.X

Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.05009.X

Simplified quantification of nicotinic receptors with 2[18F]F-A-85380 PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.05009.X

Fluoro-norchloroepibatidine: preclinical assessment of acute toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.05009.X

Alteration of the in vivo nicotinic receptor density in ADNFLE patients: a PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.05009.X

Nicotinic acetylcholine receptor distribution in Alzheimer's disease, dementia with Lewy bodies, Parkinson's disease, and vascular dementia: in vitro binding study using 5-[(125)i]-a-85380.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.05009.X

A postmortem study of brain nicotinic receptors in Parkinson's and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.05009.X

Anesthesia affects the disposition of [18F]fluoro-A-85380: a PET study in monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.05009.X

Pharmacological and toxicological evaluation of 2-fluoro-3-(2(S)-azetidinylmethoxy)pyridine (2-F-A-85380), a ligand for imaging cerebral nicotinic acetylcholine receptors with positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.05009.X

The comparative pharmacology and up-regulation of rat neuronal nicotinic receptor subtype binding sites stably expressed in transfected mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.05009.X

5-substituted derivatives of 6-halogeno-3-((2-(S)-azetidinyl)methoxy)pyridine and 6-halogeno-3-((2-(S)-pyrrolidinyl)methoxy)pyridine with low picomolar affinity for alpha4beta2 nicotinic acetylcholine receptor and wide range of lipophilicity: potent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.05009.X

10.1111/J.1471-4159.2007.05009.X

21 January 2018

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017